Podcasts about cancer treatment

Dr. Karen Mustian is an energetic, passionate scientist, world traveler, yogi, scuba diver, and foodie whose life's work is dedicated to improving the quality of life of individuals affected by cancer. Through her research, leadership, and advocacy, she strives to help cancer patients and survivors not only live longer, but live better.Dr. Mustian is a Dean's Distinguished Professor in the Department of Surgery at the University of Rochester Medical Center and an internationally recognized leader in Cancer Survivorship, Integrative Oncology, Exercise Oncology, Geriatric Oncology, Behavioral Oncology, and Gender, Sexuality, and Women's Health.She serves as Associate Director for Population Science at the Wilmot Cancer Institute, Director of the University of Rochester Cancer Center NCI Community Oncology Research Program Clinical Trial Network and Founding Director of the PEAK Human Performance Research Laboratory at the University of Rochester Medical Center. She is also a Faculty Associate with the Susan B. Anthony Institute for Gender, Sexuality, and Women's Studies.At the national level, Dr. Mustian serves on the National Cancer Institute Cancer Advisory Board Working Group for Extramural Research Concepts and Programs and the National Cancer Institute Symptom Management and Quality of Life Steering Committee, where she helps shape the future of cancer research and supportive care. Dr. Mustian has secured more than $145 million in peer-reviewed research funding and ranks among the most highly NIH-funded researchers in the United States. She has authored more than 250 scientific publications and is widely recognized for her pioneering contributions to oncology research, supportive care, and clinical trial innovation.Her accomplishments have been honored with more than 45 national and international awards, including recognition as a Fulbright Scholar, recipient of the ASCO Walther Supportive Oncology Lifetime Achievement Award, and recipient of the Prime Minister's Yoga Award for her transformative impact on yoga research worldwide. Dr. Mustian is best known for advancing evidence-based, integrative approaches to cancer care. Through groundbreaking research on yoga, tai chi, mindfulness, and exercise, she has helped establish non-pharmacologic interventions as effective strategies for reducing treatment- related toxicities, improving symptom management, and enhancing the health and well-being ofcancer patients and survivors around the globe.Support the show

Are you in control of your health? Allergies Allopaths vs homepaths Heart Disease & Cancer- Docs views on Cancer Treatment ... you'd be shocked Can you find your true north ... or is intuition gone? Has health care become the watering hole for the rich elite? Reduce variables to get answers

EVEN MORE about this episode!Join Julie Ryan for a powerful episode of the Ask Julie Ryan Show featuring live intuitive scans, energetic healings, and inspiring stories of resilience. From Australia to Connecticut and beyond, callers bring questions about chronic pain, brain cancer recovery, vision concerns, pet health, and emotional healing.A particularly moving conversation with Tracy, who is navigating brain cancer treatment, highlights the extraordinary power of hope, visualization, and collective intention. Along the way, Julie demonstrates her unique healing techniques, explores the connection between emotional and physical well-being, and reminds listeners that healing can happen on many levels.Whether you're seeking healing, supporting a loved one, or simply curious about the role of energy and intention in wellness, this episode offers inspiration, practical insights, and a powerful reminder that no one has to face life's challenges alone.Episode Chapters:(0:00:01) - Ask Julie Ryan Show(0:14:40) - Cancer Healing Energy Session With Tracy(0:23:56) - Healing Energy for Eye Conditions(0:36:54) - Healing Group Session for Hearing Loss(0:49:54) - Pet Health and Healing Consultation(0:59:09) - Healing Energy for Cancer Treatment(1:05:36) - Healing Messages From Sweet Home Alabama➡️ Subscribe to Ask Julie Ryan YouTube➡️ Julie's Intuitive Trainings✏️ Ask Julie a Question!

What if a cancerous tumour could be destroyed without a single incision, stitch or scar? A Singapore grandfather waiting for a liver transplant has become one of the first patients in Southeast Asia to undergo a breakthrough treatment called histotripsy - a technology that uses focused sound waves to destroy a liver tumour. Could this be a glimpse into the future of medicine, where cancer treatment becomes less invasive? Hosted by Michelle Martin, this episode explores the science, the human story and what innovations like histotripsy could mean for longevity and the future of cancer care. Send this episode onto someone who needs a boost of hope. Guest: Prof Brian Goh, Head of Department of Hepato-pancreato-biliary and Transplant Surgery, SGH & NCCS, and Principal Investigator of the HALT Study.See omnystudio.com/listener for privacy information.

What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology, Dr. Kelly Bree, Dr. Saum Ghodoussipour, and Meredith Donahue, N.P., join host Dr. Vignesh Packiam to discuss the power of shared decision-making across the NMIBC spectrum. They explore risk-adapted treatment selection, when to escalate or de-escalate therapy, and how to navigate conversations about recurrence risk, treatment burden, quality of life, and the possibility of cystectomy. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported by an educational grant from Johnson & Johnson. --- Timestamps 00:00 - Introduction01:55 - Second Opinions and Patient Counseling06:08 - Intermediate Risk Stratification12:13 - Treatment Options for Intermediate Risk NMIBC16:20 - BCG and Alternative Treatments for High Risk NMIBC26:49 - Options for BCG-Unresponsive NMIBC31:42 - Sequencing and Cystectomy37:03 - Financial and Time Toxicity41:08 - Biomarkers and ctDNA44:04 - Future Trials and NMIBC Innovations --- More about this episode They also review emerging therapies such as ZUSDURI, the evolving role of intravesical treatments, and the promise of biomarkers and ctDNA for personalized care. The discussion covers practical strategies for patient counseling, key updates to clinical guidelines, and a preview of innovations shaping the future of NMIBC management. --- Resources Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial:https://pubmed.ncbi.nlm.nih.gov/41571573/ Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non–Muscle-Invasive Bladder Cancerhttps://ascopubs.org/doi/10.1200/JCO-25-01324 CIRCULATING TUMOR DNA AS A BIOMARKER FOR UPSTAGING AND ADVERSE PATHOLOGY IN HIGH-RISK NON–MUSCLE-INVASIVE BLADDER CANCER:https://www.auajournals.org/doi/abs/10.1097/01.JU.0001191388.74345.c9.09 Preoperative Circulating Tumor DNA Predicts Upstaging and Recurrence in High-Risk Nonmuscle-Invasive Bladder Cancer Undergoing Radical Cystectomyhttps://pubmed.ncbi.nlm.nih.gov/41843048/ --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

Sign up for Dr Matt's FREE substack:https://substack.com/@connectiondocs Join Chef AJ's Exclusive Plant-Based Community. Become part of the inner circle and start simplifying plant-based living - with easy recipes and expert health guidance. Find out more by visiting: https://community.chefaj.com/ ORDER MY NEW BOOK SWEET INDULGENCE!!! https://www.amazon.com/Chef-AJs-Sweet-Indulgence-Guilt-Free/dp/1570674248 GET MY FREE INSTANT POT COOKBOOK: https://www.chefaj.com/instant-pot-download Disclaimer: This podcast does not provide medical advice. The content of this podcast is provided for informational or educational purposes only. It is not intended to be a substitute for informed medical advice or care. You should not use this information to diagnose or treat any health issue without consulting your doctor. Always seek medical advice before making any lifestyle changes. To book a consultation with Matt: https://form.jotform.com/241997228318164 Matthew Lederman, MD, is a board-certified Internal Medicine Physician and a pioneering thought leader in holistic health. Renowned for his innovative integration of plant-based nutrition, Nonviolent Communication (NVC), trauma-informed care, and lifestyle medicine, Dr. Lederman's work highlights the profound interconnectedness of physical, emotional, and relational well-being. As a certified Nonviolent Communication Trainer through the Center for Nonviolent Communication (CNVC), Dr. Lederman combines Polyvagal Theory, Somatic Awareness Principles, and Pain Reprocessing to empower individuals to heal from within. His approach helps people address the root causes of chronic health challenges, fostering emotional resilience and cultivating meaningful connections. Email:Support@ConnectionDocs.com Website: https://www.connectiondocs.com/ Free Resources (includes Feelings & Needs Sheet for children AND Role-Play Video “Talking to Your Child About ‘Too Much' Device Time”) : https://www.connectiondocs.com/resources Substack (Weekly Articles on Connection): https://substack.com/@connectiondocs Breath & Body Regulation Training Tool: https://webekalm.com/ webe Pärents Podcast https://webekalm.com/pages/webeparents AI Connection Coach:https://app.kinectin.com/signup Main Book WELLNESS TO WONDERFUL: 9 Pillars for Living Healthier, Longer, and with Greater Joy: https://www.amazon.com/dp/B0C2S1JGZK?ref=cm_sw_r_ffobk_cso_sms_apin_dp_K6HM5P02NNK5WAMRGE87&ref_=cm_sw_r_ffobk_cso_sms_apin_dp_K6HM5P02NNK5WAMRGE87&social_share=cm_sw_r_ffobk_cso_sms_apin_dp_K6HM5P02NNK5WAMRGE87&starsLeft=1&skipTwisterOG=1&bestFormat=true Children's E-Books (Supporting Children Bringing More Connection Into Their Lives): Healing Shame and Connecting to Self-Worth and Intrinsic Value: https://webekalm.com/products/lily-and-her-beautiful-flower Being Honest with Care https://webekalm.com/products/ella-and-the-two-gifts-ebook Supporting Children During Emergencies (fires, earthquakes, etc):'https://webekalm.com/products/brave-hearts-facing-the-fire-ebook Social Media: Instagram: https://www.instagram.com/TheConnectionDocs Substack Newsletter: https://connectionDocs.substack.com Facebook: https://www.facebook.com/connectionDocs X: https://x.com/connectionDocs

Send us Fan MailA cancer diagnosis can change everything in an instant. One conversation. Three words: "You have cancer." Suddenly, patients and families are faced with uncertainty, fear, and countless questions about what comes next.In this episode of MedStar Health DocTalk, host Debra Schindler sits down with medical oncologist and hematologist Dr. Ankit Madan of MedStar Southern Maryland Hospital Center, to discuss the critical first steps after a cancer diagnosis. Dr. Madan explains how patients move from diagnosis to treatment, how cancer is staged, and why building a multidisciplinary care team is essential for the best possible outcomes.The conversation explores the emotional impact of hearing a cancer diagnosis, the importance of patient navigators, social workers, nutritionists, mental health professionals, and the role patients play as active partners in their own care. Dr. Madan also discusses treatment advances, clinical trials, immunotherapy breakthroughs, second opinions, and practical advice for patients and families navigating one of life's most challenging journeys.Whether you or a loved one has recently been diagnosed with cancer, this episode offers guidance, reassurance, and expert insight into what happens after the diagnosis—and how patients can move forward with confidence and support.Topics covered:• Coping with the emotional impact of a cancer diagnosis• Understanding cancer staging and treatment planning• The role of biopsies, CT scans, PET scans, and additional testing• Building a multidisciplinary cancer care team• Patient navigators, social workers, and support services• Shared decision-making and patient autonomy• When to seek a second opinion• Clinical trials and emerging cancer treatments• Immunotherapy and advances in cancer care• Nutrition, exercise, and mental health during treatment• Cancer survivorship and ongoing surveillanceTo learn more about cancer care at MedStar Health, visit MedStarHealth.org/Cancer.For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

Prostate cancer treatment can bring lasting physical and emotional changes — and many men are caught off guard by how long recovery actually takes. Here is what to expect and how peer support helps. To learn more, visit https://prostaid.org/meetings/ Prostaid Calgary City: Calgary Address: 1600 90 Avenue Southwest Website: https://prostaid.org/

ChristianaCare researchers identified a developmental genetic pattern that showed how colorectal cancer develops. The findings revealed that certain types of genes drive cancer growth and resistance, and how the precise timing of how they develop is linked to colon cancer formation.The research team's work also showed the genes can predict survival in colorectal cancer patients, indicating it can be a marker of disease behavior and a target for future therapies.This week, Delaware Public Media's Joe Irizarry sat down with Bruce Boman, M.D., senior author of the study and senior researcher at ChristianaCare's Helen F. Graham Cancer Center & Research Institute to discuss this colorectal cancer research.

The latest episode of the DDW 'In Conversation With' series is available to listen to below. This week, Bruno Quinney speaks to Terry Connolly and Shinta Cheng from K36 Therapeutics. K36 is a company developing first-in-class cancer therapeutics and their current lead asset is a treatment for multiple myeloma patients. Bruno speaks to Terry and Shinta about how their NSD2 inhibitors can treat cancer, how their approach compares to other biotechs, and why K36's science could be applied to other therapeutic areas. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

Dr. Alicia Zhou is the Chief Executive Officer of the Cancer Research Institute—the oldest nonprofit in the world devoted exclusively to cancer immunology and immunotherapy. She joins Shoshana to discuss the innovations happening in cancer research, how immunotherapy is different from chemotherapy and radiation, what doctors can do to make clinical trials less intimidating, and why the conversation around cancer will change in the next 10 years. Hosted on Acast. See acast.com/privacy for more information.

Pankind CEO Michelle Stewart joined David & Will to discuss the new treatment option for pancreatic cancer.See omnystudio.com/listener for privacy information.

A man is in jail this morning for shooting his pregnant, teenage girlfriend in Bay Park. Plus, another problem with a wastewater pipeline dumping sewage into the Tijuana River. And, researchers at U.C. San Diego are using AI to help create custom cancer treatments based on a patient's genetics. NBC 7's Sergio Flores has these stories and more, including meteorologist Brooke Martell's forecast for Sunday, May 31, 2026.

FCC Chairman Brendan Carr joins after Disney filed early license renewal applications for its broadcast stations at the agency's request. Then, Erin Brockovich discusses the environmental concerns around the data center buildout and a new map she created to help track them. Plus, we take a look at what to expect from the American Society of Clinical Oncology's annual meeting, which kicks off today. Squawk on the Street Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

From Episode  #247: "Cancer and Fenbendazole: Could Parasites Be a Symptom, Not the Cause?"✨ Subscribe for the Full Episode: https://beyondlabels.supportingcast.fmFind Joel Here: www.polyfacefarms.comFind Sina Here: www.drsinamccullough.comFollow on InstagramFollow on XSubscribe on RumbleSubscribe on YouTubeDISCLAIMERGET 2DOT TICKETS HERE

Unpredictable weather is making it harder for amphibians to survive in West Virginia and elsewhere, but we learn about an effort to protect them. Also, the WVU Cancer Institute is enrolling pancreatic cancer patients for a promising, first-in-human clinical trial. The post Protecting Frogs And WVU Explores New Cancer Treatment, This West Virginia Morning appeared first on West Virginia Public Broadcasting.

 Important:To get the full benefits, you need raw, unpasteurized honey.Never heat this mixture above body temperature; heat destroys the compounds that make this combination so powerful.The Base Mixture:1 teaspoon of black seed oil1 teaspoon (or up to 2 tablespoons) of raw honeyHow to Take It:Take it on an empty stomach in the morning, and wait 30 minutes before eating.If taking it later in the day, take it at least 2 hours after a meal, or 30 minutes before a meal.If you take medication, space this mixture at least 2 hours apart from your medicine.First, consult your doctor before taking black seed oil, especially if you are on medication.1. Asthma and Breathing DifficultiesThe problem: Your airways are constricted or inflamed.Black seed oil contains Thymoquinone (TQ) , which can help open up airways by up to 60% within 3 hours.How to take: On an empty stomach in the morning and once before bed.Result: You may notice easier breathing within hours. By day 3, your lung capacity often improves dramatically.2. Weak Immune System, Allergies, Frequent InfectionsThis mixture boosts immune response by up to 89% while calming allergies and reducing infections.How to take: Same mixture as above, twice daily.For prevention: 3 times weekly.Result: Allergies often disappear completely within 4 to 6 weeks.3. Type 2 Diabetes and Blood Sugar ChaosThis mixture can reduce blood sugar levels by up to 45% and helps heal insulin resistance.How to take: 1 teaspoon black seed oil with 1 tablespoon honey, 30 minutes before your largest meal of the day.Result: Improvements within 2–3 days. Consult your doctor so they can adjust your diabetes medication if needed.4. High Blood Pressure and Heart StrainAdd a pinch of cinnamon to the base mixture. This reduces the inflammation that causes high blood pressure.Result: It can lower high blood pressure by 15 to 25 points within 2 weeks.5. Chronic Digestion Problems, IBS, and Gut IssuesWhen your gut is inflamed, everything suffers. This remedy improves digestion, mood, energy, immunity, and mental clarity.Black seed oil has antimicrobial properties that eliminate harmful bacteria, parasites, and fungi.Honey feeds the good bacteria in your gut and provides enzymes that improve digestion.How to take: Base mixture on an empty stomach, wait 30 minutes before eating.Result: Relief often comes within 24 hours. For chronic issues, improvement within 2–3 weeks.6. Chronic Inflammation, Joint Pain, and HeadachesChronic inflammation is the silent killer behind many diseases: Alzheimer's, arthritis, depression, heart disease, and cancer.How to take: Base mixture as directed. You can also apply black seed oil directly onto sore joints.Result: Joint pain often disappears within 3 to 5 days.7. Insomnia and Sleep DisordersThis mixture calms the nervous system and reduces cortisol levels.How to take: 1 teaspoon of the mixture 1 hour before bed.8. Anxiety, Depression, and Mood DisordersYour gut produces 90% of your serotonin—your "happiness chemical."How to take: Twice daily.Result: Mood control improves within 3 to 4 weeks.9. Hair LossUse this remedy both internally and externally.External use: Mix equal parts black seed oil and honey. Massage into the scalp and leave for 2 hours, then shampoo. Do this twice a week.Internal use: Take the mixture daily.Result: Improvements in hair loss within 1–2 weeks. New hair growth visible around 8 weeks.10. Skin Problems, Slow Healing, and Chronic WoundsExternal use: Apply the mixture directly to the skin and cover with a sterile bandage.Internal use: Continue taking the mixture daily.Result: Improvements within 1–2 weeks. Cuts and wounds heal much faster.11. Chronic Fatigue and Energy DepletionFatigue isn't normal—it signals that something is wrong. Common causes include inflammation, mitochondrial dysfunction, or adrenal exhaustion. This mixture addresses all of these.How to take: Take twice daily for 2 weeks, then once daily.Result: Energy levels typically improve within 3 to 5 days.12. Liver Disease, Fatty Liver, and Toxic OverloadThis mixture can help reverse liver damage. Fatty liver can be healed after about 8 months of consistent use.How to take: Twice daily, including once in the morning on an empty stomach.Result: Liver function tests often show remarkable improvement after 4 to 6 weeks.13. Obesity, Metabolic Syndrome, and Stubborn WeightObesity is often powered by inflammation. This mixture improves metabolism by 23% and reduces inflammation.How to take: 30 minutes before meals.Result: Weight comes off naturally as your metabolism heals. Most people lose 4 to 8 kg within the first month.14. Memory Loss, Brain Fog, and Cognitive DeclineYour brain needs good blood flow and low inflammation. This combination addresses both and may help reduce the plaque and tangles linked to Alzheimer's. Black seed oil increases blood circulation in the brain by up to 35%.How to take: Twice daily. Add 5 minutes of deep breathing after each dose.Result: Memory improvements after 2–3 weeks. Mental clarity returns.15. Heart Disease Prevention and RecoveryThis mixture reduces arterial inflammation, helps dissolve dangerous plaque, lowers bad cholesterol by up to 40%, improves circulation, and strengthens the heart muscle.How to take: Twice daily.Result: Consistent improvement after 6 to 8 weeks.16. Cancer Treatment and PreventionBlack seed oil has shown anti-cancer properties in over 200 studies. It may help kill cancer cells, boost the effectiveness of chemotherapy, and prevent cancer from spreading. (Always follow your doctor's advice regarding cancer treatment.)17. Autoimmune Disorders and Inflammatory DiseasesHow to take: Twice daily.Result: Improvements within 4 to 6 weeks.Important Warnings & Side EffectsDetox Reaction: This mixture detoxifies the body. You might feel unwell at the beginning as toxins are released.Stomach Sensitivity: If you have stomach problems, start with half doses to let your body adjust.Pregnancy: Avoid this mixture during pregnancy.Medication Interactions: Consult your doctor if you are taking blood-thinning medication or immune suppressive drugs.My Video: We Mixed Black Seed Oil & Honey to Treat 19 Problems https://youtu.be/pPlVxi8_FmwMy Audio: https://divinesuccess.net/wp-content/uploads/2021/Podcast5/We-Mixed-Black-Seed-Oil-Honey-to-Treat-19-Problems.mp3

Hyperbaric Oxygen Therapy (HBOT): Beyond the Bends—Wounds, Stroke Recovery, Radiation Injury, and Performance. Nicole Garrett, founder and COO of Under Pressure Hyperbarics, details hyperbaric oxygen therapy (HBOT). She explains how HBOT treats divers' decompression sickness by recompressing nitrogen bubbles and reducing inflammation, and how therapeutic benefits depend on reaching adequate pressure (commonly around 2.0 atmospheres or more; diver treatment may begin at 2.8). Garrett describes HBOT's history, FDA-approved uses such as diabetic wound healing, radiation injury, and sudden sensorineural hearing loss (often combined with steroids), and off-label use for stroke/TBI recovery, cognitive issues, autoimmune flares, Crohn's disease, athletic recovery, anti-aging research (including telomere findings), and adjunctive cancer care. She contrasts “soft” chambers with higher-pressure medical chambers, discusses treatment courses (often 10–60 sessions), safety and contraindications (ears, pneumothorax, retinal bubble procedures), and practical barriers like cost, insurance coverage, and facility/oxygen regulations.

This interview is disseminated on behalf of Medicus Pharma Ltd.In this episode of Stocks to Watch, we are joined by Medicus Pharma (NASDAQ: MDCX) Executive Chairman and CEO Dr. Raza Bokhari to discuss the company's promising Phase 2 results for SkinJect, its innovative skin cancer treatment, and what lies ahead for the company across oncology, rare diseases, and prostate cancer.Learn more about Medicus Pharma: https://medicuspharma.com/Watch the full YouTube interview here: https://youtu.be/4GZIBnS2KZ0And follow us to stay updated: https://www.youtube.com/GlobalOneMedia 

Thanks for listening, and please follow us on Insta @NHPTalent and www.youtube.com/thePOZcast For all episodes, please check out www.thePOZcast.com This special episode is brought to you by our dear friends at Blood Cancer United. An organization very near and dear to me. I'm here to remind you to give to causes that make a difference. You want to help but you don't know where to start? Blood Cancer United is at the top of my list. They are the global leader in helping patients and families with blood cancer, and your dollars fund research, patient support, and advocacy. Please give today here:  Thank you for supporting this important mission. Learn more and donate here: https://pages.lls.org/voy/nyc/nyclls26/aposner CHAPTERS: 00:00 – 500 Episodes: Introducing Geoffrey Rogow Adam opens the milestone episode, introduces Geoffrey Rogow — journalist, survivor, founder, author — and sets the tone for the most personal conversation in the show's seven-year history. 03:00 – Who Were You Before? The Person Before Treatment Geoffrey's life before diagnosis: 30 years old, living in New York and Sydney, feeling infallible, driven by professional ambition. And Adam's contrast — a father of two at 45, diagnosed only because he went to a cardiologist after his brother-in-law died. 07:00 – The Diagnosis: Two Very Different Moments Geoffrey's blood clot in the night that saved his life. Adam's cardiologist scan that caught a mass nobody expected. The two very different ways a diagnosis lands — one like a movie, one like a text message. 13:00 – Four Days vs. Six Weeks: The Window Before Treatment Geoffrey had four days between diagnosis and chemotherapy. Adam had six weeks. What that difference does to your mind, your fear, your processing — and why no two cancer stories are the same. 17:00 – The Thing Nobody Tells Young Adults: Fertility The Vanderbilt study that found 50% of young adults diagnosed with cancer are never told about their fertility options before treatment. Geoffrey's sperm banking story. Adam's moment of levity. The organizations that exist to help — and why you should use them. 23:00 – Chemotherapy: The Reality Nobody Films Steroids that make you feel like Batman. Fatigue that puts you to bed at 1 PM. The taste of treatment — Geoffrey's: a burning Nike Air Max. Adam's: Sour Patch Kids and Shrek's condom. The rhythm of treatment cycles and the crash that follows. 30:00 – Hair Loss: The Moment It Hits You Not just the hair on your head — all of it. Geoffrey's Jewish mohawk and the cat photos. Adam's man bun, the shower, the wall of clumps, the hairdresser call. Why the eyebrows and eyelashes are the part nobody prepares you for. 37:00 – Going Out in Public Without Eyebrows Geoffrey at his best friend's wedding, feeling like a freak. Adam at a bar mitzvah two weeks post-treatment, cancer beanie and all. Why "you look great" hits differently when you don't recognize yourself in the photos. 42:00 – Tribes, Villages & Crisis Language Geoffrey's lesson: his tribe was too small — just his wife and the cat. The mistake he'd change. Adam's: an oversharer married to a shield, learning to lean on his guy friends so his wife didn't have to carry everything. What "crisis language as a couple" actually means. 49:00 – Tolerance for Bullshit: The Larry David Effect What cancer does to your patience for other people's bravado. Geoffrey's bar story, running out into Times Square and crashing full speed into Elmo. The anger that's real, and the work it takes not to carry it forever. 55:00 – The Biannual Check-In: A Framework for Purposeful Change A scheduled, structured personal evaluation every six months — professional path, relationships, health, direction. The check-in that led Geoffrey to leave the Wall Street Journal after 21 years. Why you can't make the changes when the warning lights are flashing; you have to make them later, in clarity. 61:00 – Scanxiety: The Incurable Side Effect of Survivorship Geoffrey's scan is next Wednesday. He started thinking about it two weeks ago. The reality that scanxiety doesn't diminish with time — it sometimes gets worse. What helps, what stops helping, and why there's no permanent answer. 66:00 – After Treatment: The Part Nobody Celebrates The financial reality: bill negotiations, illegal anesthesiologist charges, state-specific protections, hospital programs for lower-income patients. Life insurance rejection at 35. Career decisions constrained by healthcare costs. The bills that arrive 18 months later asking "didn't I already pay this?" 73:00 – Ambition After Cancer: Don't Change the Level, Change the Lane The advice from career coach Michelle Woodward: keep the same level of ambition even if you have to find a different lane. Geoffrey's Hong Kong trip — the first time after treatment he felt like himself professionally again. Adam's silver lining of leaning into tech during treatment. 79:00 – Writing It Down: The Value of Documentation Adam's Super Whisper app diary — before and after every treatment session. Geoffrey's 14 years of running away from his cancer story, and what writing the book finally unlocked. Why every survivor should find their version of processing. 85:00 – I'm Alive: Now What? — The Book Geoffrey's nine-chapter guide for survivors — money, career, physical health, mental health, family planning, caregiving, purpose, the business of advice — built around real people's stories paired with expert guidance. Pre-order at after-treatment.com/the-book. 91:00 – Are You Getting the Support You Need? Geoffrey's question for Adam — and for every survivor. The cancer imposter syndrome that comes with a high-survival-rate diagnosis. Why you can't let anyone take away what you went through, and why the work doesn't end at remission. 97:00 – North Stars: What Keeps You Focused Geoffrey's: a willingness to change his North Star — short-term, practical, written down, evaluated regularly. Adam's: being the best example for his kids and leaving the world better than he found it. How cancer changes your definition of success. 104:00 – 500 Episodes: Thank You Adam closes the milestone episode with gratitude — for the guests, the listeners, seven years of consistency, and what comes next.   TAKEAWAYS: 1. The Diagnosis Is Never Like the Movies — Except When It Is Geoffrey's came in an ER at 30. Adam's in a text from his cardiologist. No two stories are the same — but both changed everything. 2. 50% of Young Adult Cancer Patients Are Never Told About Fertility Options A Vanderbilt study found half of young adults aren't counseled on fertility preservation before treatment starts. The window is measured in days. Make sure this conversation happens first. 3. The Biannual Check-In Is the Most Powerful Tool for Purposeful Change Twice a year, scheduled, with a workbook: evaluate your path, relationships, and direction — in calm, not crisis. The check-in that led Geoffrey to leave 21 years at the Wall Street Journal. 4. Don't Change the Level of Your Ambition — Change the Lane If cancer takes away what you were world-class at, find another lane at the same level. Don't shrink. Redirect. That's not a lesser life — it's a different one. 5. Your Relationship With Time and Bullshit Changes — But Differently for Everyone Every survivor agrees on two things: time feels different, and their tolerance for bullshit has shifted. Geoffrey went full Larry David. Adam found unexpected clarity. The work is figuring out which version of you emerged. 6. Cancer Exposes Your Crisis Language as a Couple The couples who survive this well learn how to communicate what they need, what not to say, and what to let breathe. It's practiced, not instinctive. 7. Scanxiety Is Real, Incurable, and Changes Over Time What helped before may stop helping. Survivors need to plan for this, not be surprised by it. 8. The Financial Reckoning Comes Long After Treatment Ends Medical bills stay higher forever. Many are negotiable. Some are illegal. Own the advocacy, ask the questions, build the spreadsheet. 9. Write It Down — In Whatever Form Works for You Adam used Super Whisper before and after every treatment. Geoffrey wrote a book 14 years later. The form doesn't matter. Externalizing the experience gives you a time capsule you can go back to. 10. Are You Getting the Support You Need? Just the honest, periodic question. What you went through is not nothing — and the work doesn't end at remission. 11. You Are Different Now — Not Better or Worse. Different. Not better, not worse. Fundamentally changed in ways that can't be fully accounted for. That difference isn't a loss. The work is learning to live in the new timeline.  

Dr. Robert Soiffer took an interest in medicine at an early age when he played a physician in his first-grade play.  Today, he is a leading physician, researcher, and teacher at Dana-Farber Cancer Institute, a world leader in oncology.  In this episode, Dr. Soiffer describes the incredible pace of change in the field of cancer research and treatment and the detection tools and cures that are right around the corner.  He also reflects on how he maintains a positive and optimistic outlook despite the many times he's forced to deliver terrible news to patients and families.  While he tries hard not to bring these tough times home with him, he also stresses the importance of keeping his humanity and treating his patients and their families as people, not just statistics.     Chapters:  02:29 Dana-Farber's Special Mission  Dr. Soiffer discusses what makes Dana-Farber Cancer Institute unique, emphasizing its focus on cancer patients and the common purpose among all staff.   05:50 Evolution of Cancer Treatment  This segment details the seismic shift in cancer treatment over the past 40 years, from nonspecific chemotherapy to targeted therapies focusing on specific mutations.   10:25 Bone Marrow Transplants and Graft vs. Leukemia  Dr. Soiffer delves into the history of bone marrow transplants, highlighting the Nobel Prize-winning work of E. Donald Thomas and the intriguing concept of graft versus leukemia effect.   15:02 The Role of Medical Education and Mentoring  This chapter emphasizes the critical role of medical education and mentoring in shaping the future of medicine, drawing from Dr. Soiffer's experience as chief medical resident and mentor. He discusses the mutual learning process between experienced physicians and younger generations, and the importance of continuous learning.  19:50 Personal Impact of Oncology Work  Dr. Soiffer reflects on the emotional challenges of his work, balancing optimism with realism and honesty while treating patients facing life-threatening situations. He discusses the difficulty of compartmentalizing emotions and the importance of maintaining humanity and connection with patients and their families, even when outcomes are not positive.  24:57 The Value of Clinical Trials  This chapter explains the critical role of clinical trials in advancing cancer treatment, from early-stage phase I trials to comparative studies. Dr. Soiffer describes patients participating in these trials as brave pioneers, highlighting how targeted, immune, and cellular therapies would not exist without their contributions.  28:39 Global Collaboration in Medicine  Dr. Soiffer discusses the extensive global collaboration in medical and scientific fields, emphasizing the shared mission to develop therapies for suffering patients.   35:33 Future of Cancer Treatment and Prevention  Looking ahead, Dr. Soiffer predicts less toxic and more precise cancer treatments with improved therapeutic ratios, focusing on overcoming resistance and early detection. He discusses the potential of preventing progression to full-blown malignancy through early intervention and the growing understanding of germline predispositions to cancer.  41:26 Conclusion and Call to Optimism  The episode concludes with Bill Burke thanking Dr. Soiffer for his time and invaluable insights, highlighting the rapid pace of change and innovation in cancer research. He also expresses hope and optimism for the future of cancer care. 

Have you heard of Treatment-Induced Accelerated Aging (TIAA)? It's been called the Achilles' heel for cancer survivors. But what is it and more importantly, how can it be prevented or addressed? On this show, Karolyn talks with integrative oncologist Dr. Nathan Handley, Director of the Integrative Cancer Recovery Program at the Marcus Institute of Integrative Health at Jefferson Health in Pennsylvania. Because Dr. Handley specializes in cancer recovery, he is well-versed in addressing TIAA.Five To Thrive Live is broadcast live Tuesdays at 7PM ET and Music on W4CS Radio – The Cancer Support Network (www.w4cy.com) part of Talk 4 Radio (www.talk4radio.com) on the Talk 4 Media Network (www.talk4media.com).Five To Thrive Live Podcast is also available on Talk 4 Media (www.talk4media.com), Talk 4 Podcasting (www.talk4podcasting.com), iHeartRadio, Amazon Music, Pandora, Spotify, Audible, and over 100 other podcast outlets.

For many people with cancer, exercise may help reduce fatigue, improve strength, support recovery and protect overall health. In this episode, we talk about how physical activity can help during and after treatment, how to get started safely, and why it's important to work with your care team.Featuring Dr. Jennifer Baima, a physiatrist at The Orthopedic Center at Easton, part of University of Maryland Shore Regional Health.

A major new all-island study is set to change how prostate cancer is treated, with a focus not just on survival, but on quality of life. The INSPIRE trial aims to reduce the side-effects of radiotherapy while maintaining strong cancer control, using more precise, shorter treatment methods. To discuss this, Alan Morrissey spoke with Angela Clayton-Lea, CEO of Cancer Trials Ireland and Martin Sweeney a man who was diagnosed with prostate cancer and who was involved in the design of the trial on Thursday's edition of Morning Focus. Photo (c) pixelshot via Canva.com

Register free at https://brightu.com  to watch the full Beyond The Diagnosis stream Stay informed on current events, visit www.NaturalNews.com  - Trump's Operation Freedom and Its Implications (0:11) - Trump's Tweet and the Confusion Over Operation Freedom (4:00) - The Realities of the Strait of Hormuz and Iran's Control (8:29) - The Impact of the Closed Strait of Hormuz on Global Food Supply (20:06) - Medication Spellbinding and Its Dangers (25:30) - The Role of Psychiatric Drugs in Altered Behavior (27:25) - The Spellbinding Effect of Psychiatric Drugs (32:11) - The Risks of Psychiatric Medication and Natural Alternatives (41:58) - The Future of BrighteLearn and Its Impact (51:28) - The Potential for UFO Disclosure and Its Implications (1:11:52) - FDA's Actions Against Healing Peptides and Light Therapy (1:19:20) - Jonathan Otto's Introduction and Red Light Therapy (1:23:35) - Scientific Basis of Light Therapy and Cancer Treatment (1:26:24) - Additional Light Therapy Applications and Preventive Measures (1:28:39) - Combining Light Therapy with Other Modalities (1:34:26) - Frequencies and Wavelengths in Light Therapy Devices (1:41:16) - Supply Chain Challenges and Product Availability (1:57:24) - Personal Testimonies and Real-World Applications (2:00:23) - Upcoming Event and Additional Resources (2:02:21) - Health Ranger Store Products and Final Remarks (2:04:10) Watch more independent videos at http://www.brighteon.com/channel/hrreport  ▶️ Support our mission by shopping at the Health Ranger Store - https://www.healthrangerstore.com ▶️ Check out exclusive deals and special offers at https://rangerdeals.com ▶️ Sign up for our newsletter to stay informed: https://www.naturalnews.com/Readerregistration.html Watch more exclusive videos here:

In this episode, host Rick Greene, MD, FACS, talks with Ronald J. Weigel, MD, PhD, MBA, FACS, Medical Director of ACS Cancer Programs, about a new report from the ACS National Cancer Database (NCDB) that notes key trends in cancer treatment, as well as in-depth reports on outcomes for prostate cancer, esophageal cancer, and melanoma. Dr. Weigel also describes the history of the NCDB and future plans that will lead to more rapid and robust insights on cancer occurrence and treatment. Talk about the podcast on social media using the hashtag #SurgicalReadings

Are biomarkers the missing link in personalized prostate cancer care? What is the practical role of biomarkers across the prostate cancer treatment continuum? In this episode of BackTable Urology, Dr. Udit Singhal (University of Michigan) joins Dr. Ruchika Talwar (Vanderbilt University) to explore the evolving role of genomic classifiers and biomarkers in prostate cancer care. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported byVeracytehttps://www.veracyte.com/decipher-prostate --- Timestamps 00:00 - Introduction04:58 - Current State10:07 - Interpreting High Risk Scores13:25 - Intermediate Risk Decisions16:18 - Imaging vs. Genomics18:26 - Advanced Disease Evidence22:02 - AI and Clinical Trials29:52 - Conclusions --- More about this episode They review commonly used assays, including Prolaris, Oncotype Dx, Decipher, and ConfirmMDx and emphasize how these tools complement traditional clinical and pathologic risk factors. The discussion highlights practical applications across the disease continuum from initial diagnosis and active surveillance to intermediate-risk management and post-prostatectomy salvage decisions. They also explore emerging AI-driven tools and ongoing trials, highlighting the importance of contextualizing biomarker data within the broader clinical picture and using it to inform, rather than dictate, patient-centered care. --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

Dr. Pierre Kory joins The Jeff Dornik Show for a wide-ranging conversation that starts with the medical establishment's war on low-cost therapeutics and ends with a deeper look at creation, minerals, and why Scripture keeps holding up a little better than the experts would prefer. We discuss chlorine dioxide, ivermectin, medical censorship, Big Pharma, cancer treatment, ketogenic and metabolic therapies, repurposed drugs, and the system's allergy to anything that is safe, affordable, and inconvenient to the people monetizing sickness. Then the conversation shifts into Kory's research on minerals, water, the origin of life, Genesis, the fountains of the great deep, and whether changes in the earth after Noah's Flood may help explain the dramatic decline in human lifespans. In other words, this episode manages to challenge both the pharmaceutical machine and the secular priesthood in one sitting, which is usually a decent sign that the conversation was worth having.SPONSORIf you are going to shop anyway, use Rakuten and get real cash back so you can steward your resources wisely in a world that keeps trying to take more from you. Sign up for FREE at https://jeffdornik.com/cash.Follow Dr Pierre Kory on Pickax - https://pickax.com/pierrekoryFollow Jeff Dornik on Pickax -https://pickax.com/jeffdornikBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-jeff-dornik-show--4788100/support.Follow The Jeff Dornik Show on Apple Podcasts and leave a 5-star review. That's how we reach more people and bypass Big Tech suppression.Watch LIVE daily at 7pm ET on Rumble and subscribe so you never miss a show:https://rumble.com/c/jeffdornikBig Tech is silencing truth while harvesting your data to feed the machine. That's why I built Pickax, a free speech platform where creators own their content and your voice isn't controlled. Join now:https://pickax.com/?referralCode=y7wxvwq&refSource=copy

Iran negotiations appear on the verge of collapse as the ceasefire deadline approaches, with U.S. officials preparing to travel for talks even as Iranian leadership signals it may not participate. Outrage is mounting after the IDF confirmed a soldier was responsible for smashing a statue of Jesus in southern Lebanon, prompting condemnation from Prime Minister Netanyahu and Christian leaders. FBI Director Kash Patel files a $250 million defamation lawsuit against The Atlantic, accusing the outlet of knowingly publishing false allegations about his conduct based on anonymous sources. A personalized mRNA vaccine for pancreatic cancer is showing early signs of promise in a small Phase 1 trial. California's governor's race is shifting following Eric Swalwell's exit amid scandal, with new polling showing former HHS Secretary Xavier Becerra gaining ground as a potential contender.   Birch Gold: Text MK to 989898 to join Birch Gold's Learn and Earn event by April 30!   Supersure Insurance: Simplify your business insurance and get a free coverage report at https://Supersure.com/Megyn Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Today's guest is Michael Griffith, cancer recovery coach and former CEO with a background in high-performance sport. After navigating his own throat cancer diagnosis and treatment, while supporting his wife through a terminal cancer journey, Michael saw a gap that few people talk about - what happens after treatment ends. His approach focuses on rebuilding strength, energy, and confidence through a structured, performance-based framework. Michael helps people move beyond survival and return to a life that feels capable again.We talk about being a patient and caregiver at the same time, the challenges after cancer treatment, recovery strategies and the importance of movement and connection, finding balance in recovery, learning to trust your body again, and so much more.April is Esophageal Cancer Awareness Month and Michael's story sheds a powerful light on this devastating cancer.Resources:Michael's website: www.epicwellbeing.coMichael's LinkedIn: https://www.linkedin.com/in/michael-griffith/Follow:Follow me: https://www.instagram.com/melissagrosboll/My website: https://melissagrosboll.comEmail me: drmelissagrosboll@gmail.com

What started as one man trying to make sense of prostate cancer became poetry, advocacy, and a way of helping other men feel less alone.  In this episode of The Penis Project, Melissa is joined again by Steve Jones, known to many listeners as the poet who didn't know it. Steve is now five years on from prostate cancer treatment and he reflects on PSA anxiety, recovery, poetry, weight loss, peer support, and finding purpose in the aftermath of a life-changing diagnosis. This is an honest, moving, and hopeful conversation for men, partners, and anyone navigating life after treatment.  Steve shares his experience of being diagnosed during COVID, having a radical robotic prostatectomy, and then feeling like he was left to work out the rest on his own. He speaks honestly about PSA anxiety, the emotional toll of survivorship, and the reality that even years later, follow-up testing can still stir up fear.  But this episode is not just about cancer. It is also about what can grow in the aftermath of a hard diagnosis.  Steve talks about how prostate cancer unexpectedly opened the door to poetry, advocacy, deeper connection, better health, and a renewed sense of purpose. He also shares his work with A Touchy Subject, where he helps facilitate peer support chats for men navigating prostate cancer, sexual recovery, penile implants, incontinence surgery, and the many challenges no one talks about enough.  Melissa and Steve also discuss the importance of early testing, why men need better access to holistic care after treatment, and how simple lifestyle changes like weight loss, movement, and resistance training can make a real difference to health, confidence, and recovery.  This is a moving, funny, wise conversation about fear, resilience, and making something meaningful out of a difficult experience.    About Steve  Steve Jones is a prostate cancer survivor, writer, poet, advocate, and peer support facilitator. Since his diagnosis and treatment, he has become a strong voice for men navigating prostate cancer recovery, sharing his experience through poetry, media interviews, support groups, and community advocacy.  Resources & Links:  Book a telehealth consult with our sexual health nurse practitioners at Restorative Health Clinic  For more information check out our websites www.rshealth.com.au , www.makehardeasy.com.au and www.melissahadleybarrett.com  Steve Jones' book Words Woke Me https://rshealth.com.au/shop/p/words-woke-me-prostate-cancer-poetry-book   A Touchy Subject https://www.atouchysubject.com/   Steve's previous two appearances on The Penis Project: https://thepenisproject.podbean.com/e/126-steve-the-poet-who-didn-t-know-it/  https://thepenisproject.podbean.com/e/151-words-woke-me/    True North on the Movember website https://truenorth.movember.com/   Prostate Cancer Foundation of Australia https://www.pcfa.org.au/   Need support?  At Restorative Health Clinic and Make Hard Easy, we support men and their partners with:  penile rehabilitation after prostate cancer treatment  erectile dysfunction  peyronie's disease  premature ejaculation  intimacy and sexual recovery  partner-inclusive support where appropriate  practical, evidence-based strategies for getting confidence back  We offer telehealth consultations Australia/ World-wide, making it easier for men to access experienced, compassionate support no matter where they live.    Listen & Subscribe  If you found this episode helpful, don't forget to subscribe, rate, and review the podcast! Your feedback helps us continue bringing important conversations to light. Search for The Penis Project Podcast on Spotify, Apple Podcasts, or your favourite podcast app.  Connect With Us   We love hearing from real people, navigating penile health. If you'd like to share your journey or ask a question, get in touch. Email: admin@rshealth.com.au    Websites:  https://rshealth.com.au/  All genders  https://makehardeasy.com.au   https://melissahadleybarrett.com   Instagram:  https://www.instagram.com/melissahadleybarrett/  https://www.instagram.com/restorativehealth.clinic/  YouTube: https://www.youtube.com/@melissahadleybarrett   TikTok: @melissahadleybarrett  Facebook:  https://m.facebook.com/p/Melissa-Hadley-Barrett-100085237672685/  https://www.facebook.com/profile.php?id=100085146627814  Linkedin:  https://www.linkedin.com/in/melissa-hadley-barrett/   TEDX:  https://www.youtube.com/watch?v=IjHj1YTmLoA

In this episode of the Oncology Brothers podcast, we kicked off a three-part series on colorectal cancer, starting with the current treatment algorithm. They are joined by Dr. Smitha Krishnamurthi, a GI medical oncologist from the Cleveland Clinic, who walks through the evolving standard of care from early-stage disease all the way to refractory metastatic settings. Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o Apple Podcast: https://podcasts.apple.com/us/podcast/oncology-brothers-practice-changing-cancer-discussions/id1653340966 Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Key topics discussed included: • The evolving role of ctDNA as both a prognostic and predictive tool in stage two and three colon cancer, including its utility in oligometastatic disease surveillance. • Neoadjuvant versus adjuvant immunotherapy in MSI-high resectable colon cancer, comparing the NICHE-2 and ATOMIC trial approaches and when to use each. • Single-agent versus dual checkpoint inhibition with Nivo-Ipi for MSI-high metastatic disease, based on CHECKMATE-8HW data showing a PFS hazard ratio of 0.21. • Sequencing strategies in RAS-mutant and RAS wild-type metastatic colorectal cancer, including the role of sidedness, anti-EGFR therapy, and refractory options like fruquintinib, TAS-102, and regorafenib. Join us for this comprehensive discussion on colorectal cancer management in 2026. Don't forget to like, subscribe, and check out our other episodes for more insights on oncology! #ColorectalCancer, #MSIHigh, #BRAFV600E, #ctDNA, #GIOncology, #OncologyBrothers

Got a question?

In this episode of the Oncology Brothers podcast, we dived deep into the complexities of pancreatic cancer treatment with Dr. Shubham Pant, a GI medical oncologist at MD Anderson Cancer Center. Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o Apple Podcast: https://podcasts.apple.com/us/podcast/oncology-brothers-practice-changing-cancer-discussions/id1653340966 Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Join us as we explored: • The challenges of diagnosing and treating pancreatic cancer, particularly in metastatic settings. • The importance of germline testing and next-generation sequencing (NGS) in guiding treatment decisions. • The role of neoadjuvant and adjuvant therapies, including FOLFIRINOX and Gemcitabine-based regimens. • Strategies for managing borderline resectable disease and the significance of multidisciplinary care. • The critical aspect of supportive care, including the use of pancreatic enzyme replacement therapy. • Insights into treatment options for metastatic disease, including FOLFIRINOX, NALIRIFOX, and Gemcitabine-Nab-paclitaxel. • The emerging landscape of targeted therapies for KRAS mutations and the potential of pan-RAS inhibitors. Whether you're a healthcare professional or someone interested in the latest advancements in oncology, this episode provides valuable insights into the evolving treatment algorithms for pancreatic cancer. Don't forget to like, subscribe, and hit the notification bell for more discussions on cancer treatment and care! #PancreaticCancer, #KRASmutation, #NeoadjuvantTherapy, #SupportiveCare, #OncBrothers

Dr. Babak Saboury, Chief Scientific and Innovation Officer and Physician Founder of United Theranostics, discusses the emergence of nuclear oncology as the fourth pillar of cancer care.  United Theranostics is combining advanced molecular imaging and radiopharmaceutical therapies to identify a cancer cell's unique fingerprint and then delivering targeted radiation, reducing side effects by sparing healthy cells. Molecular imaging can serve as a unifying map for guiding a collaborative, multimodal approach to treating a range of cancers.  Babak explains, "I can just very quickly tell you that there are four pillars of treating cancer. Traditionally, when we approached cancer, we wanted to cut it out. That was surgical oncology. Whatever could not be cut out was treated by giving a medication. That was medical oncology. After a while, there was just a modality to the things that were difficult to cut out, but that was a localized hit from outside. That was the radiation oncology. And right now, we are at the beginning of a new horizon. You treat patients systemically, which means all the lesions everywhere. However, you are really there, a magical radiopharmaceutical that goes to find the cell and kills it by radiation. That's a nuclear oncology. So nuclear oncology is the fourth pillar of cancer care."   "So you can imagine that in the past we tried to attack cancer cells. We didn't know what shape they had, which proteins were expressed, or what their characteristics were. So we kind of went blindly and tried to attack them. Imagine that we have a way to find a fingerprint of those cells and go there first to find that fingerprint. And if the fingerprint exists, then go after those cells as a targeted attack. That is where molecular imaging and radiopharmaceutical therapy come into play. So molecular imaging profiles the cancer cells to see what their fingerprint is and whether a certain fingerprint exists. Radiopharmaceutical therapy uses this information to target just those cells and not other cells. And that is the principle of Theranostics, which is a combination of diagnostics and therapeutics, finding and then destroying in a very precise manner." #UnitedTheranostics #NuclearOncology #PrecisionMedicine #Radiopharmaceuticals #CancerCare #MolecularImaging #Theranostics #OncologyInnovation #PatientCare #HealthcareInnovation #CancerTreatment Unitedtheranostics.com Download the transcript here

Dr. Babak Saboury, Chief Scientific and Innovation Officer and Physician Founder of United Theranostics, discusses the emergence of nuclear oncology as the fourth pillar of cancer care.  United Theranostics is combining advanced molecular imaging and radiopharmaceutical therapies to identify a cancer cell's unique fingerprint and then delivering targeted radiation, reducing side effects by sparing healthy cells. Molecular imaging can serve as a unifying map for guiding a collaborative, multimodal approach to treating a range of cancers.  Babak explains, "I can just very quickly tell you that there are four pillars of treating cancer. Traditionally, when we approached cancer, we wanted to cut it out. That was surgical oncology. Whatever could not be cut out was treated by giving a medication. That was medical oncology. After a while, there was just a modality to the things that were difficult to cut out, but that was a localized hit from outside. That was the radiation oncology. And right now, we are at the beginning of a new horizon. You treat patients systemically, which means all the lesions everywhere. However, you are really there, a magical radiopharmaceutical that goes to find the cell and kills it by radiation. That's a nuclear oncology. So nuclear oncology is the fourth pillar of cancer care."   "So you can imagine that in the past we tried to attack cancer cells. We didn't know what shape they had, which proteins were expressed, or what their characteristics were. So we kind of went blindly and tried to attack them. Imagine that we have a way to find a fingerprint of those cells and go there first to find that fingerprint. And if the fingerprint exists, then go after those cells as a targeted attack. That is where molecular imaging and radiopharmaceutical therapy come into play. So molecular imaging profiles the cancer cells to see what their fingerprint is and whether a certain fingerprint exists. Radiopharmaceutical therapy uses this information to target just those cells and not other cells. And that is the principle of Theranostics, which is a combination of diagnostics and therapeutics, finding and then destroying in a very precise manner." #UnitedTheranostics #NuclearOncology #PrecisionMedicine #Radiopharmaceuticals #CancerCare #MolecularImaging #Theranostics #OncologyInnovation #PatientCare #HealthcareInnovation #CancerTreatment Unitedtheranostics.com Listen to the podcast here

Behind every kidney cancer diagnosis is a person navigating difficult decisions about treatment and care. Today, we're diving into how to navigate the side effects of kidney cancer treatments and how to tell the difference between side effects and warning signs. This episode is supported by Exelixis.  In this episode we heard from:  Andrew Allers was diagnosed incidentally with clear-cell Renal Cell Carcinoma (RCC) in 2015 after a soccer injury. After a radical nephrectomy and four years of monitoring, Andrew's stage IV diagnosis was made in 2019 with metastases in his rib, hip, lungs and lymph nodes. The bone tumors were radiated, and after two rounds of an immunotherapy combination, a serious auto-immune reaction necessitated a pause in treatment while Andrew's care team figured out a solution. With regular IVIG infusions to manage the adverse reactions, a single-agent immunotherapy was restarted in early 2020 and within a few months a set of scans showed remarkable improvement -- tumors still visible, but "clinically unmeasurable" in the words of his oncologist. Just over a month later, a vision issue took Andrew to the local ER where he was diagnosed with two brain metastases, one of which was in the occipital lobe. The following day an emergency craniotomy was performed, followed by a round of brain radiation. Over the next 18 months, a series of 4 more brain tumors were discovered, radiated and added to the monitoring schedule. Since beginning a TKI in 2022 Andrew has been free of new brain metastases, and the immunotherapy continues to keep the lung and lymph node tumors at bay. After retiring in 2023, Andrew has become active in the Kidney Cancer community, participating in the research grant review process in the CDMRP & KCRP and as a Legislative Advocate for KidneyCAN, an advocacy group that campaigns for federally funded research into Kidney Cancer treatments. Julia Stevens, PharmD, BCOP  is a Clinical Pharmacy Specialist in Ambulatory Oncology at Beth Israel Deaconess Medical Center in Boston, MA. She collaborates with medical oncologists to care for patients with kidney cancer. Her primary clinical responsibilities include educating patients and caregivers, monitoring and supporting those on oral therapies, minimizing the financial toxicity of treatment, and providing drug information and treatment recommendations to her team. Dr. Stevens is also a member of the Kidney Cancer Association Clinical Advisory Board. Rimda Wanchoo, MD is a Professor of Medicine at the Zucker School  of Medicine and full time nephrologist at Northwell Health in NY. She graduated from medical school in India followed by residency at St. Barnabas in New Jersey and fellowship at NY Presbyterian at Weill Cornell.  Her interests are taking care of patients with cancer and kidney diseases, glomerular disease and end stage kidney disease. She has been at Northwell for the last 14 years . She also serves as director of quality for the division and medical director of the largest joint venture dialysis unit in the health system. She has published and spoken on several onconephrology topics internationally. She serves as an associate editor for JON and CKJ. She is one of the founding members of American Society of Onconephrology (ASON).   Additional Resources Kidney Cancer  Kidney Cancer: Treatment and Living Well  Voices for Kidney Health  Kidney Cancer Association (KCA)  KidneyCAN    Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.

In this episode of It Takes Balls, Jeff Pilachowski shares his journey through testicular cancer, shaped by his identity as a veteran, father of boys, business owner, and man of faith. Self-employed and responsible not just for his health, but for his livelihood, he talks about having to postpone work for a new client. That reality added another layer of pressure to an already life-altering diagnosis.What makes Jeff's story especially powerful is how he approached the mental and emotional side of cancer. At the center of it all was Jeff's faith, which became a foundation during the most difficult moments. He shares how belief, perspective, and purpose helped him process fear, uncertainty, and the reality of a cancer diagnosis—offering a different lens on what strength can look like during survivorship. Jeff also shares his experience navigating the PACT Act, having been exposed to burn pits while deployed overseas.This episode highlights the importance of recognizing testicular cancer symptoms, advocating for your health, and understanding that survivorship is about more than just treatment—it's about rebuilding physically, mentally, and spiritually.Whether you're navigating a diagnosis, supporting someone through cancer, or learning more about testicular cancer awareness and recovery, Jeff's story is a reminder that strength comes in many forms—and that no one has to face this journey alone.Provide your feedback on the podcast:https://www.testicularcancerawarenessfoundation.org/itbsurveyJoin The Ball Room:https://www.testicularcancerawarenessfoundation.org/theballroomWant to be a guest? Apply here:https://www.testicularcancerawarenessfoundation.org/it-takes-balls-submissionsConnect with Jeff:https://www.instagram.com/tetelestai_carpentry/Follow Testicular Cancer Awareness Foundation:https://www.testescancer.org⁠⁠https://www.x.com/testescancer⁠⁠https://www.instagram.com/testescancer⁠⁠https://www.facebook.com/tca.orgFollow Steven Crocker:https://www.instagram.com/stevencrockerhttps://www.facebook.com/steven.crocker2Theme song: No Time Like Now - Tom Willner www.tomwillner.com

Shaun Bagai, CEO of RenovoRx,  has designed a drug-delivery platform to treat hard-to-reach chemo-resistant tumors such as pancreatic cancer by delivering chemotherapy directly to the tumor site. The RenovoCath device increases the drug concentration in the tumor while significantly reducing systemic toxicities and side effects. The technology is not intended to replace the traditional approach using systemic chemotherapy and radiation, but to achieve better results in tumors with low blood supply that prevent drugs from reaching their target in sufficient concentrations. Shaun explains, "Generally, when we think about oncology therapies, it's really trying to balance the detriment to the patients with the toxicities and hopefully keep the tumor at bay or kill the tumor such that patients live longer. And unfortunately, we often forget about the patient and hyper-focus on the disease. And the challenge we've taken on is, can we take both into account and actually treat both the patient and the disease by limiting systemic toxicities and effects, and then trying to improve survival by keeping the tumors at bay."   "So, when we look at certain tumors in the body, like pancreatic tumors, for example, they don't have a high level of blood supply. Generally, when we think about tumors, we think of balls of blood vessels with tumor cells, and of tumors such as pancreatic tumors. They don't have large tumor feeder vessels that end in a tumor. And what this does is create a level of chemo resistance because the blood can't carry the chemotherapy forward. And what we've developed with TAMP is a mechanism where we push the drug across the wall of a blood vessel to saturate and bathe the tumor in chemotherapy, such that we get almost a hundredfold increase in tissue concentration compared to if you just gave it systemically throughout the entire body." #RenovoRx #OncologyInnovation #DrugDelivery #CancerCare #MedicalDevices #PancreaticCancer #ClinicalTrials #PatientCare #Interventionalradiology #Oncology #MedicalTechnology #TAMP #Chemotherapy #CancerTreatment #HealthcareInnovatio#TargetedOncology #InnovativeCancerTherapies #PancreaticCancerAwareness #PrecisionOncology RenovoRx.com Listen to the podcast here

Shaun Bagai, CEO of RenovoRx,  has designed a drug-delivery platform to treat hard-to-reach chemo-resistant tumors such as pancreatic cancer by delivering chemotherapy directly to the tumor site. The RenovoCath device increases the drug concentration in the tumor while significantly reducing systemic toxicities and side effects. The technology is not intended to replace the traditional approach using systemic chemotherapy and radiation, but to achieve better results in tumors with low blood supply that prevent drugs from reaching their target in sufficient concentrations. Shaun explains, "Generally, when we think about oncology therapies, it's really trying to balance the detriment to the patients with the toxicities and hopefully keep the tumor at bay or kill the tumor such that patients live longer. And unfortunately, we often forget about the patient and hyper-focus on the disease. And the challenge we've taken on is, can we take both into account and actually treat both the patient and the disease by limiting systemic toxicities and effects, and then trying to improve survival by keeping the tumors at bay."   "So, when we look at certain tumors in the body, like pancreatic tumors, for example, they don't have a high level of blood supply. Generally, when we think about tumors, we think of balls of blood vessels with tumor cells, and of tumors such as pancreatic tumors. They don't have large tumor feeder vessels that end in a tumor. And what this does is create a level of chemo resistance because the blood can't carry the chemotherapy forward. And what we've developed with TAMP is a mechanism where we push the drug across the wall of a blood vessel to saturate and bathe the tumor in chemotherapy, such that we get almost a hundredfold increase in tissue concentration compared to if you just gave it systemically throughout the entire body." #RenovoRx #OncologyInnovation #DrugDelivery #CancerCare #MedicalDevices #PancreaticCancer #ClinicalTrials #PatientCare #Interventionalradiology #Oncology #MedicalTechnology #TAMP #Chemotherapy #CancerTreatment #HealthcareInnovatio#TargetedOncology #InnovativeCancerTherapies #PancreaticCancerAwareness #PrecisionOncology RenovoRx.com Download the transcript here

The Health Minister's announced 14 new cancer treatment infusion centres will be rolled out countrywide over the next two years. Services at a further 14 existing sites will also be expanded. Simeon Brown says the investment's supported by $210 million, announced in Budget 2024 to upgrade facilities on the back of a Pharmac funding boost. He told Mike Hosking they're expecting around 13,000 additional cancer transfusions – the exact number of patients will depend on the number of transfusions they need based on their treatment type. Brown says they're focusing on prevention, but when people are diagnosed, they need to make sure they receive treatments in a timely manner, closer to home. LISTEN ABOVE See omnystudio.com/listener for privacy information.

In this episode of the Oncology Brothers, we welcomed Dr. Suneel Kamath from the Cleveland Clinic to discuss the complex landscape of biliary tract cancer. While this cancer type is not the most common, it carries a poor prognosis, making it crucial for oncologists to stay informed about the latest treatment options. Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o Apple Podcast: https://podcasts.apple.com/us/podcast/oncology-brothers-practice-changing-cancer-discussions/id1653340966 Follow us on social media: ⁠X/Twitter: https://twitter.com/oncbrothers Instagram: https://www.instagram.com/oncbrothers Website: https://oncbrothers.com/ Join us as we explored: The role of surgery and adjuvant chemotherapy in early-stage biliary tract cancer. Frontline treatment strategies for metastatic disease, including insights from the TOPAZ-1 and KEYNOTE-966 studies. The importance of biomarker testing, including HER2, IDH1, and FGFR mutations, and how they influence treatment decisions. Management of side effects associated with various therapies, including immunotherapy and chemotherapy. The emerging landscape of targeted therapies and the need for more effective treatment options. Whether you're a medical professional or someone interested in oncology, this episode provides valuable insights into the current treatment algorithms and challenges in managing biliary tract cancer. Don't forget to like, subscribe, and hit the notification bell for more episodes from the Oncology Brothers! #BiliaryTractCancer, #Cholangiocarcinoma, #Immunotherapy, #BiomarkerTesting, #OncologyBrothers

In this special rebroadcast, we honor the memory of Kelly U'Ren Moody, a devoted advocate and colleague who passed away on January 16, 2026. This conversation, originally recorded in September 2021, captures Kelly's extraordinary spirit as she navigated a terminal oral cancer diagnosis. After being told in 2016 that she had only four to six months to live, Kelly went on to live a full, impactful life for nearly another decade.Kelly's story is a testament to the power of gratitude and the unfiltered reality of long-term survivorship. She shares how she transitioned from a career in finance to health coaching just as her diagnosis changed her life, and how she chose to "face it head-on" every single day.In this Episode:Navigating the TerminalThe Reality of Side EffectsThe Power of GratitudeCommunicating with Loved OnesTranscript: https://bit.ly/podscript181About Kelly: Kelly was the creator of the blog Face It Head On, where she shared her journey with head and neck cancer to provide hope to others worldwide. Her legacy lives on through the lives she touched and the advocacy work she championed within the cancer community.Visit Kelly's SocialsFacebook: https://www.facebook.com/KellyURenMoodyLinkedIn: https://www.linkedin.com/in/kellyurenmoody/Instagram: https://www.instagram.com/kellyurenmoo/Book: https://a.co/d/09KgBORmOriginal recording: https://podcast.ausha.co/navigatingcancertogether/living-looking-beyond-6-monthsVideo: The Fight of my Life, https://youtu.be/DmcXbbUDzykSupport the Podcast: If this episode resonated with you, please consider sharing it with someone who needs a dose of hope today. You can also rate and review Navigating Cancer TOGETHER on Apple Podcasts or Spotify to help more people find these stories.Connect & Engage with Talaya: https://solo.to/cancerdoula

In our analysis of a poignant blog post penned in 2012, we delve into the intricate experience of navigating chemotherapy as illustrated by Bill Risser. The central theme revolves around the unexpected ramifications of abruptly ceasing a long-standing caffeine habit amidst the challenges of cancer treatment. We explore how the interplay of aggressive medical regimens and daily routines can yield unforeseen complications, highlighting Bill's profound seven-day headache, which he initially attributed solely to chemotherapy. Through this examination, we uncover the significance of patient-led insights in medical care, emphasizing how personal habits can deeply influence one's treatment journey. Join us as we unpack the complexities of this narrative, shedding light on the resilience of the human spirit in the face of adversity. In an impassioned dialogue, the hosts unpack the complexities of navigating cancer treatment while grappling with the sudden loss of daily comforts. The episode meticulously outlines Risser's experiences following his initial chemotherapy session, particularly emphasizing the psychological burden of interpreting pain. The discussion reveals the dangers of attributing all discomforts to the effects of chemotherapy without recognizing the broader context of one's lifestyle and habits. The hosts also emphasize the importance of patient-led knowledge, advocating for open communication between patients and healthcare providers, particularly regarding the impact of dietary habits on treatment outcomes. Through Risser's narrative, the episode ultimately champions the resilience of the human spirit, showcasing how humor and camaraderie can emerge in the most challenging of circumstances.Takeaways:In this episode, we delve into Bill Risser's personal reflections on his cancer journey, particularly focusing on his experiences during chemotherapy.The significant impact of sudden caffeine withdrawal is examined, illustrating how it can mimic severe chemotherapy side effects.We discuss the psychological effects of chemotherapy, emphasizing the importance of maintaining one's identity and normalcy during treatment.The infusion center is depicted as a space of unexpected camaraderie and humor, challenging traditional perceptions of cancer treatment environments.Bill's story serves as a poignant reminder of the interconnectedness of daily habits and health, highlighting how minor changes can have profound effects.The episode underscores the necessity of patient-led knowledge, revealing how personal insights can enhance medical understanding and care.

In this episode, we're joined by Katrina Foe as she shares her personal journey of overcoming breast cancer through a fully holistic, natural approach. Now a board-certified holistic and functional nutritionist, Katrina is a passionate advocate for addressing the root causes of disease through targeted nutrition, lifestyle changes, and functional medicine. What sets her approach apart? Katrina sits down to break down the philosophy behind her methods and how focusing on the body's internal environment can play a key role in supporting healing and long-term health…. Click play to discover: The role of diet and lifestyle in supporting the body during illness. Key principles for addressing root causes rather than symptoms. How Katrina's experience shaped her mission to help others take control of their health. The importance of testing when it comes to identifying cancer causes.  Curious about how Katrina's journey from patient to practitioner has challenged conventional thinking and inspired others? Tune in to explore a different perspective on healing and what it can look like to take a more natural, integrative path. Connect with Katrina by visiting Cancerfreedom.com.

Cancer treatment advocates are asking lawmakers to support legislation (House Bill 4339/Senate Bill 809) that would ensure insurance coverage of comprehensive biomarker testing. This legislation has passed in 23 other states so far and Massachusetts appears to be falling behind on this... The American Cancer Society Cancer Action Network (ACS CAN) volunteers, including survivors and patients from across Massachusetts, gathered on Beacon Hill to meet with lawmakers as part of its annual Cancer Action Day to urge them to support proposals that address the needs of cancer patients and reduce health disparities. Marc Hymovitz with the American Cancer Society discussed the MA legislation, what it includes, how it would help cancer patients, and why there is a need for this legislation in MA.See omnystudio.com/listener for privacy information.

Send us Fan MailLife after cancer treatment ~ The long road to recovery Penny Mitchell is a breast cancer survivor & cancer wellness mentor.She shares her story to help & inspire others.Penny trained as a chef and loved working in hospitality, which led her to travel abroad.She was diagnosed with breast cancer at 47, just before lockdown which came as a big shock. We discuss her journey, and how she struggled to get back to health & when she went back to work. We look at her strategies and positive practices she employed to help her recover. She likes to support others with health & wellbeing on their cancer journey.Her treatment includes tamoxifen, which she will be on for ten years, and has side effects. Connect with Penny:InstagramArts for healthMilton Keynes Hospital charityThe Hair & Skin Clinic Hair & Scalp Salon Specialist course Support the showConnect with Hair therapy:FacebookInstagramTwitterClubhouse- @Hair.TherapyDonate towards the podcast Start your own podcastHair & Scalp Salon Specialist Course ~ Book now to become an expert! 

The Nurses Report on America Out Loud with Ashley Caputo, RN, FMP – Ashley Caputo explores growing interest in alternative cancer therapies, including repurposed medications, immune-supportive compounds, and metabolic approaches. The discussion examines patient demand for options beyond conventional oncology while highlighting debate around emerging research, medical freedom, and evolving perspectives in cancer care...

"Our goal of precision oncology has been to shift to tailored therapies that can help to improve treatment efficacy and ultimately improve patient outcomes. Resistance biomarker testing can help the care team to detect these genomic changes that the tumor may have acquired during therapy that makes the cells resistant to therapy. This information can be extremely helpful when we're talking about making choices about second-line or subsequent-line therapy," ONS member Danielle Fournier, DNP, APRN, AGPCNP-BC, AOCNP®, advanced practice RN at the University of Texas MD Anderson Cancer Center in Houston, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about drug resistance biomarker testing. This podcast episode is sponsored by AstraZeneca. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Episode Notes  This episode is not eligible for NCPD credit.  ONS Podcast™ episodes: Episode 389: Biomarker Testing for Non-Small Cell Lung Cancer Episode 373: Biomarker Testing in Prostate Cancer Episode 169: How Biomarker Testing Drives the Use of Targeted Therapies ONS Voice articles: Help Your Patients Understand Biomarker Resistance Testing Key Patient Education Points for Biomarker Resistance Testing Quick Quiz: How Much Do You Know About Drug Resistance in Cancer? Quick Quiz: How Much Do You Know About Somatic Biomarker Resistance Testing? When Targeted Therapy Stops Working, What's Next? Discover How Biomarker Resistance Testing Opens New Doors ONS Biomarker Database Clinical Journal of Oncology Nursing article: Tumor-Agnostic Therapies Reshaping Cancer Care ONS book: Understanding Genomic and Hereditary Cancer Risk: A Handbook for Oncology Nurses ONS course: Genomic Foundations for Precision Oncology ONS Genomics and Precision Oncology Learning Library American Cancer Society Cancer Action Network: Access to Biomarker Testing page White paper: The Landscape of Biomarker Testing Coverage in the United States Find out which states are currently discussing biomarker testing bills and how you can advocate for them through ONS. To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "We know that biomarkers are playing an ever more important role in cancer care, and really, their use can range anywhere from helping us to confirm a given diagnosis, understand a patient's cancer susceptibility or risk, evaluate prognosis, as well as personalize treatment recommendations. … But in some cases, though, biomarkers can also help us to avoid therapies that are not likely to work. We also call these drug resistance biomarkers. These are those biomarkers that signify that a tumor is unlikely to respond to a given therapy." TS 1:50 "Resistance to cancer therapies is one of the most common issues that arises during cancer treatment. Because the populations of cancer cells within a tumor can be very diverse, when a given drug kills the cells that are sensitive to that therapy, it can also eventually leave behind resistant tumor cells, which can grow and multiply over time. So this can ultimately lead to a point where the treatment that was initially effective is no longer able to control the disease." TS 4:33 "While costs have come down, there can still be a cost associated with biomarker testing, and in some cases, this can be considered a barrier to care. What patients pay out of pocket can vary widely depending on their insurance coverage. So we have some data that was published from the American Cancer Society Cancer Action Network, and this was published a few years ago in 2023, which showed the average allowed unit cost to insurers per biomarker test ranged anywhere from about $79 for patients who were on Medicaid to about $224 for large-group, self-insured patients." TS 10:03 "There's research underway that's looking not only at genomic changes—so DNA changes that impact drug resistance—but how other substances such as RNA and proteins within the cell can also contribute to drug resistance. And this kind of falls into not just genomics but multiomics field. I have no doubt whatsoever that the use of artificial intelligence and machine learning is likely going to play a large role in drug resistance research. And really, these tools can help researchers to analyze complex data sets, identify novel resistance biomarkers, predict resistance patterns, as well as help to develop treatments that may overcome some of those resistance mechanisms." TS 17:00